Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Kierstin Utter"'
Autor:
Michael Lattanzi, Joseph Han, Una Moran, Kierstin Utter, Jeremy Tchack, Rachel Lubong Sabado, Russell Berman, Richard Shapiro, Hsin-Hui Huang, Iman Osman, Nina Bhardwaj, Anna C. Pavlick
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 6, Iss 1, Pp 1-10 (2018)
Abstract Background Cancer-testis antigen NY-ESO-1 is a highly immunogenic melanoma antigen which has been incorporated into adjuvant vaccine clinical trials. Three such early-phase trials were conducted at our center among patients with high-risk re
Externí odkaz:
https://doaj.org/article/fd1e2c8d12284a4da542561e33954d18
Publikováno v:
JMIR Mental Health, Vol 7, Iss 10, p e19171 (2020)
JMIR Mental Health
JMIR Mental Health
Background Gender and race are known to impact attitudes toward mental health topics and help-seeking behavior. Men and minorities are more likely to cite stigma as a reason for not seeking help for mental health concerns, which is of particular rele
BACKGROUND Gender and race are known to impact attitudes toward mental health topics and help-seeking behavior. Men and minorities are more likely to cite stigma as a reason for not seeking help for mental health concerns, which is of particular rele
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::12b0d8c9531e692c831a34628d66669d
https://doi.org/10.2196/preprints.19171
https://doi.org/10.2196/preprints.19171
Autor:
Iman Osman, Chloe Goldman, Anna C. Pavlick, Melissa Wilson, Kierstin Utter, Richard L. Shapiro, Russell S. Berman, Sarah A. Weiss
Publikováno v:
Oncology. 93:249-258
Background: Metastatic melanoma of unknown primary (MUP) is uncommon, biologically ill defined, and clinically understudied. MUP outcomes are seldom reported in clinical trials. In this study, we analyze responses of MUP patients treated with systemi
Autor:
Russell S. Berman, Brooke E Rosenbaum, Judy Zhong, Iman Osman, Richard L. Shapiro, Una Moran, Melissa Wilson, Kierstin Utter, Anna C. Pavlick, Farbod Darvishian, David Polsky
Publikováno v:
Melanoma Res
BACKGROUND: Patients diagnosed with metastatic melanoma have varied clinical courses, even in patients with similar disease characteristics. We examine the impact of initial stage of melanoma diagnosis, BRAF status of primary melanoma, and receiving
Autor:
Joseph Han, Kierstin Utter, Anna C. Pavlick, Michael Lattanzi, Jeremy Tchack, Rachel Lubong Sabado, Nina Bhardwaj, Iman Osman, Una Moran, Russell S. Berman, Richard L. Shapiro, Hsin-Hui Huang
Publikováno v:
Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 6, Iss 1, Pp 1-10 (2018)
Journal for ImmunoTherapy of Cancer, Vol 6, Iss 1, Pp 1-10 (2018)
Background Cancer-testis antigen NY-ESO-1 is a highly immunogenic melanoma antigen which has been incorporated into adjuvant vaccine clinical trials. Three such early-phase trials were conducted at our center among patients with high-risk resected me
Autor:
Farbod Darvishian, Richard L. Shapiro, David Polsky, Sung Won Han, Iman Osman, Eleazar Vega-Saenz de Miera, Anna C. Pavlick, Melissa Wilson, Kierstin Utter, Judy Zhong, Brooke E Rosenbaum, Una Moran, Russell S. Berman
Publikováno v:
Journal of Clinical Oncology. 34:9550-9550
9550Background: Time to metastatic recurrence from primary melanoma diagnosis is known to vary based on original stage at diagnosis. However, little is known on whether recurrent melanoma originati...